Incannex Healthcare

End of the list of the largest biotech companies in Australia is Incannex Healthcare. It is a clinical-stage pharmaceutical development company focused on the development of novel medicinal cannabis pharmaceutical products and psychedelic medicine therapies for the treatment of anxiety disorders, obstructive sleep apnea (OSA), traumatic brain injury (TBI)/concussion, lung inflammation (ARDS, COPD, asthma, bronchitis), rheumatoid arthritis, and inflammatory bowel disease.

As it develops its products and therapies in collaboration with its medical and scientific advisory board and partners, Incannex has a strong patent filing strategy in place. It has a diverse portfolio of 28 unique research and development (R&D) activities, 6 clinical trials now active, and more planned.

Its objective is to alleviate human suffering by developing innovative and ethical medications and therapies for patients with unmet medical needs, utilizing compounds and delivery systems with strong pre-existing scientific effectiveness evidence. The company is pursuing FDA registration and marketing approval for each product and therapy under development.

Founded: 2015

Headquarters: Melbourne, VIC, Australia

Website: https://www.incannex.com/